PrintFriendly

Print Friendly, PDF & Email

New CME-Accredited Activity on Evaluating Patients with Suspected VWD

March 21, 2019
New CME-Accredited Activity on Evaluating Patients with Suspected VWD

Register today for a new CME-accredited educational activity on “Recognizing and Remediating von Willebrand Disease - A Case Study in Collaborative Care,” provided by Haymarket Medical Education and the National Hemophilia Foundation. Supported by an educational grant from CSL Behring, the content for this new web-based activity is being presented by Jonathan C. Roberts, MD, Associate Medical Director of the Bleeding and Clotting Disorders Institute of Peoria, Illinois and Assistant Professor of Pediatrics at the University of Illinois College of Medicine.

Because von Willebrand disease (VWD) presents in many healthcare settings, it is important for clinicians in primary care to better recognize and respond to possible cases of this bleeding disorder and refer patients to hematologists for appropriate workup and treatment. This case study emphasizes the importance of collaborative care of the VWD patient over his or her lifetime and outlines the respective roles of primary care and hematology specialists.

This case study presentation is intended for physician assistants, primary care physicians, hematologists, and nurse practitioners with an interest in VWD.

Learning Objectives

After completing the case activity, the participant should be better able to:

  • Recognize the signs and symptoms of VWD and its underlying pathophysiology
  • Perform family and personal history, physical examination, and appropriate laboratory testing upon suspicion of VWD and refer patients with relevant histories and exams to a hematologist
  • Customize VWD care plans by considering indications, mechanism of action, safety, and efficacy of treatment choices, and provide appropriate follow-up and care coordination
  • Counsel and educate patients with VWD on managing risk and sustaining health and quality of life

The activity has been designated for 0.50 AMA PRA Category 1 Credit(s)TM.  It will remain available for credit at myCME.com until March 14, 2020.